HHS Accelerates Shift to Human-Based Research, Reduces Reliance on Animal Testing - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

HHS Promotes Transition to Human-Centric Research Approaches, Minimizing Animal Testing

  • By

  • Assistant Secretary for Public Affairs (ASPA)

  • September 21, 2026

Share

  • 1

    HHS announced a coordinated initiative to modernize biomedical research by prioritizing human-based methods and reducing unnecessary animal testing.

  • 2

    Over 20 efforts have been initiated by HHS agencies to increase the use of human organoids, tissue models, and artificial intelligence in research.

  • 3

    The FDA is revising regulations to decrease animal studies in drug development, potentially sparing hundreds of non-human primates annually.

  • 4

    NIH is investing over $88 million in infrastructure to develop and validate human-based research methods and has closed its final beagle laboratory.

  • 5

    CDC is reducing its laboratory animal colony and rigorously reviewing proposed animal research to align with public health priorities.

Original Source(s)

HHS Accelerates Shift to Human-Based Research, Reduces Reliance on Animal Testing

  • by Assistant Secretary for Public Affairs (ASPA)

  • September 21, 2026

Related Content

Microsporidial keratoconjunctivitis may mimic allergy

Molecular testing identified Encephalitozoon hellem in a 9-year-old orthokeratology lens wearer after conventional treatment failed.

Nirsevimab may curb RSV severity

Real-world estimates showed protection across emergency, inpatient, and intensive care settings during Canada’s first universal immunization season.

FDA approves combo for ESR1-mutated breast cancer

In an exploratory subgroup analysis of patients with ESR1-mutated tumors, median progression-free survival was 11.1 months with the combination and 5.5 months with imlunestrant alone.